Sector Update: Health Care Stocks Edge Higher Premarket Thursday

MT NewswiresJan 2 09:12 ET

Express News | HUTCHMED Shares Are Trading Higher After the Company Announced the Divestment of Its 45% Interest in Shanghai Hutchison Pharmaceuticals

BenzingaJan 2 08:01 ET

Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million

BenzingaJan 2 07:38 ET

6-K: Report of foreign private issuer (related to financial reporting)

SECJan 2 06:07 ET · Announcements

HUTCHMED (China) Combination Cancer Treatment Gets NDA; Share Prices Up 5%

MT NewswiresJan 2 02:16 ET

Reported Wednesday, HUTCHMED Divests 45% Stake In Shanghai Hutchison Pharmaceuticals For $608M To Focus On Core R&D And Innovative Oncology Therapies

BenzingaJan 2 01:11 ET